While the disease-modifying therapies have been very effective at reducing relapses, they do nothing to reverse existing neurological damage. The panel talks about the investigational treatments being studied now that may lead to remyelination and neurologic repair.
With the impending patent expiration of Copaxone (glatiramer acetate injection), treatment may be dictated by insurance companies moving forward. Also, hear the experts discuss the topic of vaccinations for patients with MS.
Since there is no set treatment algorithm for MS, it can be difficult to know what to do when a patient wants to stop taking medication. Here, the panelists discuss various scenarios in which discontinuation may or may not be a valid option.
When a doctor prescribes any medication it is done so with the assumption that patients will follow the dosage given by the provider. This is considerably more important for medications like anticoagulants which can help prevent potentially fatal strokes from occurring.
Sometimes health stories can be just downright strange, and even the most experienced physicians may scratch their heads from time to time. Whether it was strange ingredients to treat pain or foods that harmfully impact the body, there have been a fair share of wild occurrences in the past 12 months.
Researchers compared the B cells of patients with multiple sclerosis and healthy patients, specifically examining granulocyte macrophage colony stimulating factor (GM CSF), in order to determine their role in interactions between other immune cells within MS.
Part of an ongoing series that takes a high-level look at the positions of the leading nominees for President when it comes to political issues potentially impacting physicians, this installment focuses on Ben Carson.